ARTICLE | Company News
Uni-Bio, Jiangsu Hansoh in diabetes deal
November 25, 2015 2:25 AM UTC
Uni-Bio Science Group Ltd. (HKSE:690) gained exclusive, worldwide rights to mitiglinide from Jiangsu Hansoh Pharmaceutical Co. Ltd. (Lianyungang, China). Uni-Bio said China FDA has approved the insulin secretagogue as a first or second-line treatment for Type II diabetes. ...